Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.613
-0.028 (-4.42%)
Dec 20, 2024, 4:00 PM EST - Market closed
Lyell Immunopharma Employees
Lyell Immunopharma had 224 employees as of December 31, 2023. The number of employees decreased by 50 or -18.25% compared to the previous year.
Employees
224
Change (1Y)
-50
Growth (1Y)
-18.25%
Revenue / Employee
$281
Profits / Employee
-$910,665
Market Cap
171.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 224 | -50 | -18.25% |
Dec 31, 2022 | 274 | 55 | 25.11% |
Dec 31, 2021 | 219 | 29 | 15.26% |
Dec 31, 2020 | 190 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Accuray | 987 |
Organigram Holdings | 984 |
Alector | 244 |
Genfit | 159 |
Nektar Therapeutics | 137 |
BrainsWay | 134 |
Profound Medical | 131 |
EUDA Health Holdings | 106 |
LYEL News
- 12 days ago - Lyell Presents Positive Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the Treatment of B-cell Lymphoma at the 2024 ASH Annual Meeting - GlobeNewsWire
- 6 weeks ago - Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 7 weeks ago - Lyell Immunopharma Completes Acquisition of ImmPACT Bio - GlobeNewsWire
- 2 months ago - Lyell Immunopharma: Oversold And Poised For A Turning Point To Growth - Seeking Alpha
- 2 months ago - Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies - GlobeNewsWire
- 2 months ago - Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewsWire
- 3 months ago - Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day - GlobeNewsWire
- 4 months ago - Lyell Immunopharma Announces Participation in September Investor Conferences - GlobeNewsWire